Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

13 Canadian Crypto ETFs (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

How Could Trump's US Election Win Affect the Gold Price?

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Trending Press Releases

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

Bitcoin Well Provides Update to the Bitcoin Super Company Vision and Bitcoin Reserve Fund

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

Results of Updated Scoping Study for Nueva Sabana Mine, Cuba

More Press Releases
Trending Companies

Silver47 Exploration

AGA:CC

Purpose Bitcoin ETF

BTCC:CA

Osisko Metals

OM:CA

Syntheia

SYAI:CC
More Companies
Trending Reports

2024 Gold Outlook Report

2024 AI Market Outlook Report

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Amplia Therapeutics Limited

ASX:ATX

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis.

Press Releases

Interim Data from Accent Pancreatic Cancer Trial Supports Continuation of Trial

Tumour Response in Sixth Patient Triggers Additional Recruitment in Pancreatic Cancer Trial

FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Interactive Chart

×